PureTech Health
Randy Holmes-Farley is a seasoned professional in the biotechnology and pharmaceutical sectors, currently serving as Vice President of Discovery at Entrega, a division of PureTech Health, since August 2018. Previously, Randy held roles including Director of Product Development at Gel4Med, Inc., and Consultant at Holmes-Farley Consulting, where expertise was provided to various firms, including NASA. As Chief Technology Officer at PixarBio Corporation, Randy contributed significantly to the development of biomaterials for drug delivery systems. Randy also had a distinguished tenure at Genzyme (GelTex and Sanofi), advancing therapeutic polymer research and co-inventing several pharmaceutical polymers. Early career experience includes positions at GTE Laboratories and Lord Corporation. Educational qualifications include a PhD in Chemistry from Harvard University and a summa cum laude BA in Chemistry and Biology from Cornell University.
This person is not in any teams
This person is not in any offices
PureTech Health
4 followers
PureTech (Nasdaq: PRTC, LSE: PRTC) is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others.